Operational and supply chain strategy
We have deep expertise in this field, developed over many years. Applying our extensive benchmarking databases and understanding of operational key performance indictors - such as overall equipment effectiveness and total inventory - we are able to measure and improve the efficiency of our clients’ assets and processes, thereby reducing their manufacturing costs.
Bottom-line benefit
A mid-size pharmaceutical manufacturer estimates that for every billion dollars in pharmaceutical revenue, each percentage point improvement in OEE is worth $7 million in savings.
Pharmawise have developed a world-class team of operational experts and associates in this field. We focus on key related sectors:
- Pharmaceutical branded(rx); Generic (gx); and Over-the-counter (OTC)
- Medical device
Our proprietary know-how includes specialist databases and operational benchmarking across the pharmaceutical industry. Offering our clients a path to low-cost goods, production efficiencies and improved customer service, we provide:
- Rapid analytics
- Portfolio management
- Conversion cost assessment
- Cost driver analysis
- Capacity assessment
- Opportunity assessment from supply
optimisation/planning improvements - Quality cost driver benchmarks
- Inventory benchmarking
- Third party deal review
- Distribution optimisation (primary and secondary)
- Procurement and API source optimisation